Clinical Trial Update: A Long Term Follow-Up Study for Asian Adult Patients With Attention Deficit Hyperactivity Disorder [Phase 3]

View source ↗

Summary

This clinical trial update reports long-term safety and efficacy results from a Phase 3 study of atomoxetine in Asian adults with Attention Deficit Hyperactivit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED | Results posted: 2012-12-12